Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167140 · ClinicalTrials.gov registry record · Phase 2
Cryo-Touch II for the Treatment of Wrinkles
A Phase 2 study of Facial Wrinkles, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01167140 is a Phase 2 study of Facial Wrinkles that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 42 participants, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01167140, a Phase 2 study of Facial Wrinkles, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.
Conditions Studied
Interventions
- DEVICE Cryo-Touch II
Study Locations (1)
California
- The Aesthetics Research Center - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01167140
The ClinicalTrials.gov registry entry for NCT01167140 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (47% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Cryo-Touch II is the first listed.
NCT01167140 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01167140 about?
NCT01167140 is a clinical study titled "Cryo-Touch II for the Treatment of Wrinkles". This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.
What is the current status of trial NCT01167140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2010-07. Estimated completion is 2011-04.
What conditions does trial NCT01167140 study?
This clinical trial studies the following conditions: Facial Wrinkles.
What interventions are being tested in trial NCT01167140?
The interventions under investigation include: Cryo-Touch II (DEVICE).
Who is sponsoring clinical trial NCT01167140?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01167140 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
COMPLETED · Phase 2
-
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
COMPLETED · NA
-
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
COMPLETED · Phase 3
-
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.